SJ
Sangita Jain
About Sangita Jain
Data last updated:
Sangita Jain is a Director at Hindustan Serum & Biogenetic Corporation Private Limited (since 2026), Director at Win Formulation Private Limited (since 2025) and Director at Fytokem Healthcare Private Limited (since 2024), and holds 1 more current directorship. The companies operate in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Sep 2026 | 2026 | Active | ||
| Director | 22 Oct 2025 | 2025 | Active | ||
| Director | 21 Jan 2024 | 2024 | Active | ||
| Director | 04 May 2023 | 2023 | Active |
Board colleagues of Sangita Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Jain | 09248508 | Hindustan Serum & Biogenetic Corporation Private Limited , Win Formulation Private Limited and 2 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sangita Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sangita Jain
Sangita Jain currently holds 4 directorships: Hindustan Serum & Biogenetic Corporation Private Limited (Director, since 01 Sep 2026); Win Formulation Private Limited (Director, since 22 Oct 2025); Fytokem Healthcare Private Limited (Director, since 21 Jan 2024); Tcf Pharmaceuticals Private Limited (Director, since 04 May 2023).
Sangita Jain was first appointed on 04 May 2023 as Director at Tcf Pharmaceuticals Private Limited. The most recent appointment on record is 01 Sep 2026 at Hindustan Serum & Biogenetic Corporation Private Limited.
The current boards of Sangita Jain's companies include Amit Jain (Hindustan Serum & Biogenetic Corporation Private Limited).